華工科技(000988.SZ):具備硅光芯片到模塊的全自研設計能力,高端光芯片基本實現自主可控
格隆匯7月18日丨華工科技(000988.SZ)在投資者互動平台表示,智能製造業務領域,公司擁有國內領先的激光裝備研發、製造技術和工業激光領域全產業鏈優勢,主要產品涵蓋全功率系列的激光切割系統、激光焊接系統、智能製造產線和智慧工廠建設等;聯接業務領域,公司具備硅光芯片到模塊的全自研設計能力,高端光芯片基本實現自主可控;感知業務領域,公司自主掌握傳感器用敏感陶瓷芯片製造和封裝工藝的核心技術,自主掌握核心智能控制技術,不斷豐富温度、壓力、濕度、氣體、光、雨量等敏感元器件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.